Literature DB >> 7593645

Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine.

M Stumvoll1, U Chintalapudi, G Perriello, S Welle, O Gutierrez, J Gerich.   

Abstract

Despite ample evidence that the kidney can both produce and use appreciable amounts of glucose, the human kidney is generally regarded as playing a minor role in glucose homeostasis. This view is based on measurements of arteriorenal vein glucose concentrations indicating little or no net release of glucose. However, inferences from net balance measurements do not take into consideration the simultaneous release and uptake of glucose by the kidney. Therefore, to assess the contribution of release and uptake of glucose by the human kidney to overall entry and removal of plasma glucose, we used a combination of balance and isotope techniques to measure renal glucose net balance, fractional extraction, uptake and release as well as overall plasma glucose appearance and disposal in 10 normal volunteers under basal postabsorptive conditions and during a 3-h epinephrine infusion. In the basal postabsorptive state, there was small but significant net output of glucose by the kidney (66 +/- 22 mumol.min-1, P = 0.016). However, since renal glucose fractional extraction averaged 2.9 +/- 0.3%, there was considerable renal glucose uptake (2.3 +/- 0.2 mumol.kg-1.min-1) which accounted for 20.2 +/- 1.7% of systemic glucose disposal (11.4 +/- 0.5 mumol.kg-1.min-1). Renal glucose release (3.2 +/- 0.2 mumol.kg-1.min-1) accounted for 27.8 +/- 2.1% of systemic glucose appearance (11.4 +/- 0.5 mumol.kg-1.min-1). Epinephrine infusion, which increased plasma epinephrine to levels observed during hypoglycemia (3722 +/- 453 pmol/liter) increased renal glucose release nearly twofold (5.2 +/- 0.5 vs 2.8 +/- 0.1 mol.kg-1.min-1, P = 0.01) so that at the end of the infusion, renal glucose release accounted for 40.3 +/- 5.5% of systemic glucose appearance and essentially all of the increase in systemic glucose appearance. These observations suggest an important role for the human kidney in glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593645      PMCID: PMC185914          DOI: 10.1172/JCI118314

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

Review 1.  ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE.

Authors:  R C DEBODO; R STEELE; N ALTSZULER; A DUNN; J S BISHOP
Journal:  Recent Prog Horm Res       Date:  1963

2.  Distribution along the rat nephron of three enzymes of gluconeogenesis in acidosis and starvation.

Authors:  H B Burch; R G Narins; C Chu; S Fagioli; S Choi; W McCarthy; O H Lowry
Journal:  Am J Physiol       Date:  1978-09

3.  Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture.

Authors:  P E Cryer; J V Santiago; S Shah
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

4.  Liver and kidney metabolism during prolonged starvation.

Authors:  O E Owen; P Felig; A P Morgan; J Wahren; G F Cahill
Journal:  J Clin Invest       Date:  1969-03       Impact factor: 14.808

5.  The contrasting responses of splanchnic and renal glucose output to gluconeogenic substrates and to hypoglucagonemia in 60-h-fasted humans.

Authors:  O Björkman; P Felig; J Wahren
Journal:  Diabetes       Date:  1980-08       Impact factor: 9.461

6.  Characteristics of ammoniagenesis and gluconeogenesis by the diabetic kidney. In vitro studies in the rat.

Authors:  G Lemieux; M Achkar; P Vinay; A Gougoux
Journal:  Contrib Nephrol       Date:  1982       Impact factor: 1.580

7.  Effects of glucose and insulin on metabolism and function of perfused rat kidney.

Authors:  C M Gregg; J J Cohen; A J Black; M A Espeland; M L Feldstein
Journal:  Am J Physiol       Date:  1978-07

8.  Ultrastructural observations on renal glycogen in normal and pathologic human kidneys.

Authors:  C Biava; A Grossman; M West
Journal:  Lab Invest       Date:  1966-01       Impact factor: 5.662

9.  Insulin resistance in uremia.

Authors:  R A DeFronzo; A Alvestrand; D Smith; R Hendler; E Hendler; J Wahren
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

10.  Renal net glucose release in vivo and its contribution to blood glucose in rats.

Authors:  K Kida; S Nakajo; F Kamiya; Y Toyama; T Nishio; H Nakagawa
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

View more
  51 in total

1.  Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism.

Authors:  P She; M Shiota; K D Shelton; R Chalkley; C Postic; M A Magnuson
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.

Authors:  M K Hellerstein; R A Neese; P Linfoot; M Christiansen; S Turner; A Letscher
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  The kidney is an important site for in vivo phenylalanine-to-tyrosine conversion in adult humans: A metabolic role of the kidney.

Authors:  N Møller; S Meek; M Bigelow; J Andrews; K S Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 4.  Stress hyperglycemia in pediatric critical illness: the intensive care unit adds to the stress!

Authors:  Vijay Srinivasan
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

5.  Effect of prior exercise on the partitioning of an intestinal glucose load between splanchnic bed and skeletal muscle.

Authors:  K S Hamilton; F K Gibbons; D P Bracy; D B Lacy; A D Cherrington; D H Wasserman
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 6.  Targeting the CNS to treat type 2 diabetes.

Authors:  Darleen A Sandoval; Silvana Obici; Randy J Seeley
Journal:  Nat Rev Drug Discov       Date:  2009-05       Impact factor: 84.694

7.  The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects.

Authors:  X Chen; N Iqbal; G Boden
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 8.  Role of the kidney in hyperglycemia in type 2 diabetes.

Authors:  Christian Meyer; John E Gerich
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 9.  Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.

Authors:  Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

10.  Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.

Authors:  Ling Hinshaw; Ashwini Mallad; Chiara Dalla Man; Rita Basu; Claudio Cobelli; Rickey E Carter; Yogish C Kudva; Ananda Basu
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-07       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.